US 10662430
RNA interference in ocular indications
granted A61KA61K31/713A61K45/06
Quick answer
US patent 10662430 (RNA interference in ocular indications) held by Phio Pharmaceuticals Corp. expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Phio Pharmaceuticals Corp.
- Grant date
- Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/713, A61K45/06, A61K47/554, A61K9/0048